TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI ® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American ...
In a statement signed by the agency's Director-General, Jide Idris, and shared with PREMIUM TIMES on Wednesday, the health body said the case is the only confirmed infection so far.The Nigeria Centre ...
Voters cast ballots on a state constitutional amendment that would pave the way for a new congressional map designed to help ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
Transformed Medicaid TAF analyses evaluated OUD diagnosis, MOUD receipt, 180-day continuation, and OUD-related ...
A University of Queensland study has shown Large Language Models (LLMs) used in AI content moderation may be prone to subtle ...
A father claims he has created the world’s “most inclusive” marathon, featuring runners of all shapes and sizes and those ...
Medicaid coverage of highly effective disease-modifying therapies for MS varies widely across the U.S., with no coverage in ...
Cerebrospinal fluid (CSF) analysis has long been an essential tool in the study and management of neurological diseases, particularly multiple sclerosis ...
Cardiovascular care is transitioning from primarily managing acute conditions to focusing on prevention and interventions for ...
The FDA has approved an expanded indication for the CD3-directed monoclonal antibody teplizumab-mzwv to delay stage 3 type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results